1. Fokkens W, Lund V, Hopkins C, Hellings P, Kern R, Reitsma S, Toppila-Salmi S, Bernal-Sprekelsen M, Mullol J, Alobid I, Anselmo-Lima W, Bachert C, Baroody F, Von Buchwald C, Cervin R, Cohen N, Constantinidis J, De Gabory L, Desrosiers M, Diamant Z, Douglas R, Gevaert P, Hafner A, Harvey R, Joos G, Kalogjera L, Knill A, Kocks J, Landis B, Limpens J, Lebeer S, Lourenco O, Matricardi P, Meco C, O’mahony L, Philpott C, Ryan D, Schlosser R, Senior B, Smith T, Teeling T, Tomazic P, Wang D, Wang D, Zhang L, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;Supplement 29:1–464.
2. Kern RC, Stolovitzky JP, Silvers SL, et al. A phase 3 trial of mometasone furoate sinus implants for chronic sinusitis with recurrent nasal polyps. Int Forum Allergy Rhinol. 2018;8:471–81.
3. Han JK, Forwith KD, Smith TL, et al. RESOLVE: a randomized, controlled, blinded study of bioabsorbable steroid-eluting sinus implants for in-office treatment of recurrent sinonasal polyposis. Int Forum Allergy Rhinol. 2014;4:861–70.
4. Forwith KD, Han JK, Stolovitzky JP, et al. RESOLVE: bioabsorbable steroid-eluting sinus implants for in-office treatment of recurrent sinonasal polyposis after sinus surgery: 6-month outcomes from a randomized, controlled, blinded study. Int Forum Allergy Rhinol. 2016;6:573–81.
5. Harvey RJ, Snidvongs K, Kalish LH, Oakley GM, Sacks R. Corticosteroid nasal irrigations are more effective than simple sprays in a randomized double-blinded placebo-controlled trial for chronic rhinosinusitis after sinus surgery. Int Forum Allergy Rhinol. 2018;8:461–70.